Healthcare Services

Global Hepatitis C Testing Industry Trends and Market Growth Forecast for 2026–2030

April 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Large Is The Hepatitis C Testing Market Projected To Become By 2030 Based On Its 2026 Valuation?

The hepatitis c testing market has experienced strong growth in recent years. It is projected to expand from $1.32 billion in 2025 to reach $1.4 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 6.4%. The historical growth of this market can be attributed to the expansion of blood screening programs, an increasing prevalence of hepatitis c infections, improved diagnostic awareness, the availability of advanced testing kits, and the growth in public health surveillance initiatives.

The hepatitis C testing market is anticipated to experience substantial expansion over the upcoming years. This market is projected to reach $1.78 billion by 2030, progressing at a compound annual growth rate (CAGR) of 6.1%. Factors contributing to this growth during the forecast period include the surge in global elimination programs, a heightened need for point-of-care diagnostic solutions, wider availability of molecular testing, increased funding for infectious disease diagnostics, and an intensified emphasis on prompt intervention. Key trends observed within the forecast timeframe encompass the wider embrace of rapid diagnostic tests, an escalating reliance on molecular testing technologies, a concentrated effort towards early disease detection, the broadening scope of high-throughput laboratory testing, and improved oversight of treatment results.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24559&type=smp

What Primary Drivers Are Shaping The Development Of The Hepatitis C Testing Market?

The increasing incidence of hepatitis cases is anticipated to drive expansion in the hepatitis C testing market moving ahead. Hepatitis C, a viral infection, inflames the liver and can result in severe liver damage if not addressed. The surge in hepatitis cases primarily stems from low vaccination coverage, which leaves many vulnerable and promotes the virus’s dissemination. Early detection of the virus through hepatitis C testing enables timely treatment, preventing liver damage and significant complications. Furthermore, it identifies infected people, aiding in preventing its transmission and improving disease management. For instance, in April 2024, according to the World Health Organization (WHO), a Switzerland-based intergovernmental organization responsible for global public health, over 50 million individuals globally are living with chronic hepatitis C virus infection, with approximately 1.0 million new infections arising each year. Consequently, the growing occurrence of hepatitis cases is a key factor propelling the expansion of the hepatitis C testing market.

What Segment Groups Are Identified Within The Hepatitis C Testing Market?

The hepatitis c testing market covered in this report is segmented –

1) By Test Type: Antibody Tests, Nucleic Acid Tests, Genotyping Tests

2) By Technology: Enzyme-Linked Immunosorbent Assay (ELISA), Rapid Diagnostic Tests, Polymerase Chain Reaction, Next-Generation Sequencing

3) By Application: Blood Screening, Viral Load Monitoring, Disease Diagnosis

4) By End-User: Hospital-Based Laboratories, Stand-Alone Laboratories, Other End-Users

Subsegments:

1) By Antibody Tests: Enzyme Immunoassay (EIA), Recombinant Immunoblot Assay (RIBA), Rapid Diagnostic Tests (RDTs)

2) By Nucleic Acid Tests (NATs): Quantitative Ribonucleic Acid (RNA) Tests, Qualitative Ribonucleic Acid (RNA) Tests, Transcription-Mediated Amplification (TMA), Reverse Transcription Polymerase Chain Reaction (RT-PCR)

3) By Genotyping Tests: Line Probe Assay (LiPA), Sequencing-Based Assay, Real-Time Polymerase Chain Reaction (PCR)-Based Genotyping

Which Trends Are Influencing The Hepatitis C Testing Market?

Prominent companies operating in the hepatitis C testing market are concentrating on creating advanced solutions, including dual antigen-antibody diagnostic tests, to facilitate more efficient screening and oversight of the infection. This diagnostic method identifies both viral proteins (antigens) and immune response proteins (antibodies), allowing for the detection of active and prior infections. This combined strategy provides a comprehensive assessment of the infection status. For example, in July 2023, Roche Diagnostics India Pvt. Ltd., an India-based supplier of diagnostic tests and systems, introduced Elecsys HCV Duo. This fully automated immunoassay can simultaneously and independently detect both HCV antigens and antibodies from a single plasma or serum sample. This advancement supports early diagnosis, aids patient management, and aligns with India’s national goal to eliminate hepatitis C through timely and thorough screening.

Which Companies Hold Significant Positions In The Hepatitis C Testing Market?

Major companies operating in the hepatitis c testing market are F. Hoffmann-La Roche Ltd., Bayer AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Quest Diagnostics Incorporated, Hologic Inc., QuidelOrtho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., SD Biosensor INC., QIAGEN N.V., DiaSorin S.p.A., Cepheid, OraSure Technologies Inc., Meridian Bioscience Inc., Trivitron Healthcare Private Limited, General Biologicals Corporation, Biogate Laboratories Ltd., Cosara Diagnostics Private Limited, BioGenex Life Sciences Private Limited

Read the full hepatitis c testing market report here:

https://www.thebusinessresearchcompany.com/report/hepatitis-c-testing-global-market-report

How Does The Hepatitis C Testing Market Perform Across Major Global Regions?

North America was the largest region in the hepatitis C testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hepatitis c testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Hepatitis C Testing Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24559&type=smp

Browse Through More Reports Similar to the Global Hepatitis C Testing Market 2026, By The Business Research Company

Hepatitis Diagnostic Tests Global Market Report

https://www.thebusinessresearchcompany.com/report/hepatitis-diagnostic-tests-global-market-report

Covid 19 Rapid Test Kits Global Market Report

https://www.thebusinessresearchcompany.com/report/covid-19-rapid-test-kits-global-market-report

Viral Hepatitis Global Market Report

https://www.thebusinessresearchcompany.com/report/viral-hepatitis-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795